A detailed history of Sapient Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Sapient Capital LLC holds 2,930 shares of AMGN stock, worth $820,429. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,930
Previous 2,903 0.93%
Holding current value
$820,429
Previous $907,000 4.08%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$309.38 - $337.38 $8,353 - $9,109
27 Added 0.93%
2,930 $944,000
Q2 2024

Jul 15, 2024

BUY
$262.75 - $319.31 $8,933 - $10,856
34 Added 1.19%
2,903 $907,000
Q1 2024

Apr 22, 2024

BUY
$268.87 - $324.56 $1,344 - $1,622
5 Added 0.17%
2,869 $816 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $107,905 - $121,730
-422 Reduced 12.84%
2,864 $825 Million
Q4 2023

Jan 29, 2024

BUY
$255.7 - $288.46 $840,230 - $947,879
3,286 New
3,286 $946 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sapient Capital LLC Portfolio

Follow Sapient Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sapient Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sapient Capital LLC with notifications on news.